Latigo Biotherapeutics (LTGO) Financials: Revenue & Earnings
LTGO$15.81+0.60 +3.97%
$951.26M
Market Cap
—
P/E
—
Forward P/E
—
Score
Latigo Biotherapeutics (LTGO) Financials: Revenue & Earnings
LTGO price $15.81 +0.60 +3.97%
- Ticker
- LTGO
- Price
- $15.81
- Change
- +0.60 +3.97%
- Market cap ?
- $951.26M
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Fair value
LTGO fair value Not meaningful. Price $15.81.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-09-03 | -27.59 | -0.62 | — | — |
Dividends
Yield —. Payout ratio —. Frequency —.
Safety score 34/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. Yield is unknown, so this part stays neutral.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-10 | 5AM Ventures VI, L.P. | Buy | 4.98M | — | — |
| 2026-08-10 | 5AM Ventures VI, L.P. | Buy | 2.35M | — | — |
| 2026-08-10 | 5AM Ventures VI, L.P. | Sell | 3.15M | — | — |
| 2026-08-10 | 5AM Ventures VI, L.P. | Sell | 866.02K | — | — |
| 2026-08-10 | 5AM Ventures VI, L.P. | Sell | 1.48M | — | — |
| 2026-08-10 | Sanofi | Buy | 177.98K | — | — |
| 2026-08-10 | Sanofi | Buy | 494.80K | — | — |
| 2026-08-10 | Sanofi | Sell | 494.80K | — | — |
| 2026-08-10 | Sanofi | Sell | 177.98K | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 1.03M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 165.52K | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 1.48M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 3.55M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 3.46M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 2.07M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Buy | 938.98K | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Sell | 165.52K | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Sell | 938.98K | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Sell | 3.55M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Sell | 2.07M | — | — |
| 2026-08-10 | Westlake BioPartners Fund I, L.P. | Sell | 1.48M | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 445.32K | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 296.88K | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 3.12M | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 195.78K | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 140.00K | $18.00 | 2.52M |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 742.20K | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Buy | 1.13M | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Sell | 3.12M | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Sell | 296.88K | — | — |
| 2026-08-10 | Foresite Capital Management V, LLC | Sell | 195.78K | — | — |
| 2026-08-10 | Tananbaum James B. | Buy | 445.32K | — | — |
| 2026-08-10 | Tananbaum James B. | Buy | 296.88K | — | — |
| 2026-08-10 | Tananbaum James B. | Buy | 3.12M | — | — |
| 2026-08-10 | Tananbaum James B. | Buy | 195.78K | — | — |
| 2026-08-10 | Tananbaum James B. | Buy | 140.00K | $18.00 | 2.52M |
| 2026-08-10 | Tananbaum James B. | Buy | 742.20K | — | — |
| 2026-08-10 | Tananbaum James B. | Buy | 1.13M | — | — |
| 2026-08-10 | Tananbaum James B. | Sell | 296.88K | — | — |
| 2026-08-10 | Tananbaum James B. | Sell | 3.12M | — | — |
| 2026-08-10 | Tananbaum James B. | Sell | 3.12M | — | — |
| 2026-08-10 | Tananbaum James B. | Sell | 195.78K | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 1.03M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 165.52K | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 1.48M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 3.55M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 3.46M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 2.07M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Buy | 938.98K | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Sell | 938.98K | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Sell | 3.55M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Sell | 2.07M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Sell | 1.48M | — | — |
| 2026-08-10 | SEIDENBERG BETH C | Sell | 165.52K | — | — |
| 2026-08-06 | Sanofi | Other | 494.80K | — | — |
| 2026-08-06 | Sanofi | Other | 177.98K | — | — |
| 2026-08-06 | SMITH TODD N | Buy | 105.54K | $18.00 | 1.90M |
| 2026-08-06 | Foresite Capital Management V, LLC | Other | 3.12M | — | — |
| 2026-08-06 | Foresite Capital Management V, LLC | Other | 296.88K | — | — |
| 2026-08-06 | Foresite Capital Management V, LLC | Other | 195.78K | — | — |
| 2026-08-06 | 5AM Ventures VI, L.P. | Other | 3.15M | — | — |
| 2026-08-06 | 5AM Ventures VI, L.P. | Other | 866.02K | — | — |
| 2026-08-06 | 5AM Ventures VI, L.P. | Other | 1.48M | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 0 | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 0 | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 0 | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 938.98K | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 3.55M | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 2.07M | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 1.48M | — | — |
| 2026-08-06 | Westlake BioPartners Fund I, L.P. | Other | 165.52K | — | — |
| 2026-08-06 | Raidy Kevin | Other | 0 | — | — |
| 2026-08-06 | Walbert Timothy P | Other | 259.77K | $2.19 | 568.90K |
| 2026-08-06 | Walbert Timothy P | Other | 31.14K | $5.53 | 172.18K |
| 2026-08-06 | Krishnamohan Neha | Other | 9.90K | $5.53 | 54.72K |
| 2026-08-06 | Krishnamohan Neha | Other | 580.48K | $5.98 | 3.47M |
| 2026-08-06 | SMITH TODD N | Other | 0 | — | — |
| 2026-08-06 | Bonstein Sara | Other | 105.54K | $8.16 | 861.22K |
| 2026-08-06 | Singla Neil | Other | 613.47K | $2.19 | 1.34M |
| 2026-08-06 | Singla Neil | Other | 98.96K | $5.53 | 547.25K |
| 2026-08-06 | Farzan Nima | Other | 0 | — | — |
| 2026-08-06 | Farzan Nima | Other | 1.70M | $2.19 | 3.73M |
| 2026-08-06 | Farzan Nima | Other | 272.14K | $5.53 | 1.50M |
| 2026-08-06 | Tananbaum James B. | Other | 3.12M | — | — |
| 2026-08-06 | Tananbaum James B. | Other | 296.88K | — | — |
| 2026-08-06 | Tananbaum James B. | Other | 195.78K | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 0 | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 0 | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 0 | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 938.98K | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 3.55M | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 2.07M | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 1.48M | — | — |
| 2026-08-06 | SEIDENBERG BETH C | Other | 165.52K | — | — |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Latigo Biotherapeutics Inc. (LTGO) trades at $15.81, with a market cap of $951.26M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn